172 related articles for article (PubMed ID: 12504956)
1. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
Nisell H; Wolff K
BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
[No Abstract] [Full Text] [Related]
2. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
3. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
4. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
5. Using atosiban in uterine contractions of early pregnancies after assisted reproduction.
Wu MY; Chen SU; Yang YS
J Formos Med Assoc; 2011 Dec; 110(12):800. PubMed ID: 22248840
[No Abstract] [Full Text] [Related]
6. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
Lyndrup J; Lamont RF
Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
8. Atosiban for preterm labour.
Tsatsaris V; Carbonne B; Cabrol D
Drugs; 2004; 64(4):375-82. PubMed ID: 14969573
[TBL] [Abstract][Full Text] [Related]
9. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J; Connolly M; Rath W
BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
[TBL] [Abstract][Full Text] [Related]
10. Atosiban.
Shubert PJ
Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
[TBL] [Abstract][Full Text] [Related]
11. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin antagonists for tocolysis in preterm labour -- a systematic review.
Coomarasamy A; Knox EM; Gee H; Khan KS
Med Sci Monit; 2002 Nov; 8(11):RA268-73. PubMed ID: 12444392
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide.
Nanetti L; Raffaelli F; Giulietti A; Sforza G; Raffaele Giannubilo S; Ciavattini A; Tranquilli AL; Mazzanti L; Vignini A
J Matern Fetal Neonatal Med; 2015 Mar; 28(5):611-6. PubMed ID: 24920283
[TBL] [Abstract][Full Text] [Related]
14. Emerging issues over the choice of nifedipine, beta-agonists and atosiban for tocolysis in spontaneous preterm labour--a proposed systematic review by the International Preterm Labour Council.
Beattie RB; Helmer H; Khan KS; Lamont RF; McNamara H; Svare J; Tsatsaris V; van Geijn HP;
J Obstet Gynaecol; 2004 Apr; 24(3):213-5. PubMed ID: 15203610
[No Abstract] [Full Text] [Related]
15. Preterm labour. The present and future of tocolysis.
Giles W; Bisits A
Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
Coomarasamy A; Knox EM; Gee H; Song F; Khan KS
BJOG; 2003 Dec; 110(12):1045-9. PubMed ID: 14664874
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
19. Preterm labor: current tocolytic options for the treatment of preterm labor.
Jørgensen JS; Weile LK; Lamont RF
Expert Opin Pharmacother; 2014 Apr; 15(5):585-8. PubMed ID: 24456411
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin receptor antagonists for inhibiting preterm labour.
Papatsonis D; Flenady V; Cole S; Liley H
Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
